HFI-142
HFI-142 is an insulin-regulated aminopeptidase (IRAP) inhibitor with a Ki of 2.01 μM[1].
Product Specifications
CAS Number
332164-34-8
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Aminopeptidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/hfi-142.html
Purity
99.55
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
CCOC(C1=C(N)OC2=CC(O)=CC=C2C1C3=CN=CC=C3)=O
Molecular Formula
C17H16N2O4
Molecular Weight
312.32
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362-P403+P233-P405-P501
References & Citations
[1]Albiston AL, et al. Phenylalanine-544 plays a key role in substrate and inhibitor binding by providing a hydrophobicpacking point at the active site of insulin-regulated aminopeptidase. Mol Pharmacol. 2010 Oct;78 (4) :600-7.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSV030166 100 µg
Recombinant EBOV (subtype Zaire, strain Mayinga 1976) GP-RBD / Glycoprotein Protein (His Tag)
Sign In for Pricing
View Details 
